Clinical Trial Update: Lutein by Scleral Iontophoresis in AMD

View source ↗

Summary

A clinical trial evaluating lutein delivered via scleral iontophoresis for stage 3 age-related macular degeneration is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lutein (lutein)

Snippet

Sponsor: Federico II University | Conditions: Stage 3 AMD | Status: RECRUITING